Weinstein Gregory S, O'Malley Bert W, Snyder Wendy, Sherman Eric, Quon Harry
Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania Health System, Philadelphia, PA 19104, USA.
Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1220-6. doi: 10.1001/archotol.133.12.1220.
To describe and show the feasibility of a new surgical technique for transoral robotic surgery (TORS) radical tonsillectomy.
A prospective, phase 1 clinical trial.
Academic, tertiary referral center.
A total of 27 participants were prospectively selected using a volunteer sample. All eligible patients agreed to participate in the study.
Patients underwent TORS radical tonsillectomy for previously untreated invasive squamous cell carcinoma of the tonsillar region without free-flap reconstruction, staged neck dissection, and adjuvant therapy.
Outcome measures included final pathologic margin status, need for short- and long-term tracheotomy tube placement, and need for gastrostomy tube feedings among patients with a minimum 6-month follow-up. The incidence of significant postoperative complications was recorded.
No mortality occurred. Final margins found to be negative for cancer were achieved in 25 of 27 patients (93%). Surgical complications included 1 case each of postoperative mucosal bleeding, delirium tremens, unplanned tracheotomy for temporary exacerbation of sleep apnea, and hypernasality and 2 cases of moderate trismus. Twenty-six of 27 patients (96%) were swallowing without the use of a gastrostomy.
Radical tonsillectomy using TORS is a new technique that offers excellent access for resection of carcinomas of the tonsil with acceptable acute morbidity. Future reports will focus on long-term oncologic and functional outcomes.
描述并展示一种经口机器人手术(TORS)根治性扁桃体切除术新手术技术的可行性。
一项前瞻性1期临床试验。
学术性三级转诊中心。
采用志愿者样本前瞻性选取了27名参与者。所有符合条件的患者均同意参与研究。
患者接受TORS根治性扁桃体切除术,用于治疗先前未经治疗的扁桃体区域浸润性鳞状细胞癌,不进行游离皮瓣重建、分期颈部清扫和辅助治疗。
观察指标包括最终病理切缘状态、短期和长期气管切开管放置需求,以及在至少随访6个月的患者中胃造瘘管喂养需求。记录严重术后并发症的发生率。
无死亡病例。27例患者中有25例(93%)最终病理切缘癌阴性。手术并发症包括术后黏膜出血、震颤谵妄、因睡眠呼吸暂停暂时加重而进行的非计划性气管切开、鼻音过重各1例,以及中度牙关紧闭2例。27例患者中有26例(96%)无需胃造瘘即可吞咽。
使用TORS进行根治性扁桃体切除术是一种新技术,可为扁桃体癌切除提供良好的手术入路,急性发病率可接受。未来的报告将聚焦于长期肿瘤学和功能结局。